Oxford BioDynamics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-27.34-136.21-74.99-43.65-97.02-29.66-21.88-6.12-1.70-5.04-5.73-97.02
Price/Sales ratio
30.54195.00118.92140.37159.7791.58207.04120.1174.45106.9915.1891.58
Price/Book Value ratio
3.8515.1616.7914.349.464.726.966.134.439.015.734.72
Price/Cash Flow ratio
-47.46-111.38-96.24-108.82-97.57-36.57-27.75-6.92-2.21-6.57-6.77-97.57
Price/Free Cash Flow ratio
-43.56-78.13-83.38-85.11-69.71-28.61-24.47-4.54-1.88-6.05-5.19-69.71
Price/Earnings Growth ratio
0.901.70-0.92-0.391.94-0.82-0.40-0.110.25-0.55-0.31-0.82
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
30.65%58.11%52.70%65.59%41.56%48.40%-36.40%-163.34%75.32%52.15%46.32%41.56%
Operating Profit Margin
-116.08%-177.06%-213.38%-338.37%-219.39%-410.47%-1085.74%-2202.93%-5585.06%-2161.96%-352.46%-352.46%
Pretax Profit Margin
-111.68%-143.16%-190.10%-340.82%-204.30%-373.31%-1076.75%-2237.24%-4913.63%-2237.45%-322.01%-322.01%
Net Profit Margin
-111.68%-143.16%-158.57%-321.55%-164.67%-308.71%-945.83%-1959.53%-4357.14%-2122.74%-264.98%-264.98%
Effective Tax Rate
-3.94%-23.68%16.58%5.65%19.39%17.30%12.15%12.41%11.32%5.12%17.70%17.70%
Return on Assets
-11.90%-10.31%-19.17%-30.00%-9.32%-14.89%-28.09%-43.44%-59.15%-67.12%-22.81%-14.89%
Return On Equity
-14.10%-11.13%-22.39%-32.86%-9.75%-15.93%-31.79%-100.08%-259.27%-178.79%-39.38%-15.93%
Return on Capital Employed
-14.61%-13.74%-29.89%-34.35%-12.93%-21.05%-35.19%-57.41%-101.99%-90.92%-40.82%-21.05%
Liquidity Ratios
Current Ratio
N/AN/AN/A11.6023.8715.3010.00N/AN/AN/A0.9415.30
Quick Ratio
6.4013.136.6811.5123.6915.089.752.740.831.720.3415.08
Cash ratio
5.7912.085.9010.5122.234.694.750.940.331.310.334.69
Days of Sales Outstanding
317.36N/A285.04N/A368.69476.06N/A2.08KN/A1.17KN/A476.06
Days of Inventory outstanding
18.3678.2174.2780.7176.89189.51189.54159.333.23K409.87234.6376.89
Operating Cycle
335.7378.21359.3180.71445.59665.58189.542.24K3.23K1.58K234.63665.58
Days of Payables Outstanding
43.92100.56194.52228.68153.26843.08179.56155.268.23K725.511.39K153.26
Cash Conversion Cycle
291.80-22.34164.78-147.97292.32-177.499.972.09K-4.99K860.23-1.33K-177.49
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.77N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.38N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.67N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.70N/A
Interest Coverage Ratio
N/AN/AN/A-2.51KN/AN/A-260.57N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-0.35N/A
Company Equity Multiplier
1.181.071.161.091.041.061.132.304.382.664.381.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.64-1.75-1.23-1.28-1.63-2.50-7.45-17.35-33.61-16.26-2.24-2.24
Free Cash Flow / Operating Cash Flow Ratio
1.081.421.151.271.391.271.131.521.171.081.301.27
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-0.35N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-2.97N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A